Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailender Bhatia

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
Current Treatment Options in Oncology|February 26, 2013
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinomaNatalie J Miller, Shailender Bhatia, Upendra Parvathaneni, et al.
Journal of the American Academy of Dermatology|March 12, 2025
Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapyKelly G Paulson, Song Y Park, Shailender Bhatia, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for ImmunotherapyEvan T Hall, Elena Fernandez-Lopez, Ann W Silk, et al.
JAAD Case Reports|June 26, 2023
Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvecNeha Singh, Erin McClure, Coley Doolittle-Amieva, et al.
Cancer Medicine|January 30, 2020
Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer centerEvan Hall, Jenny Zhang, Eun Jeong Kim, et al.
Expert Review of Anticancer Therapy|January 20, 2017
Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologistsYolanda D Tseng, Smith Apisarnthanarax, Jay J Liao, et al.
The American Journal of Case Reports|May 1, 2018
Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 PatientsErica S Tarabadkar, Hannah Thomas, Astrid Blom, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapyTomoko Akaike, Austin J Jabbour, Peter H Goff, et al.
Neuro-Oncology|December 30, 2016
Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanomaMarc C Chamberlain, Christina S Baik, Vijayakrishna K Gadi, et al.
Oncoimmunology|November 11, 2017
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinomaDirk Schadendorf, Paul Nghiem, Shailender Bhatia, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
Current Treatment Options in Oncology|February 26, 2013
Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinomaNatalie J Miller, Shailender Bhatia, Upendra Parvathaneni, et al.
Journal of the American Academy of Dermatology|March 12, 2025
Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapyKelly G Paulson, Song Y Park, Shailender Bhatia, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|March 25, 2020
Immunologic Characteristics of Nonmelanoma Skin Cancers: Implications for ImmunotherapyEvan T Hall, Elena Fernandez-Lopez, Ann W Silk, et al.
JAAD Case Reports|June 26, 2023
Complete resolution of PD-1 refractory, locoregionally advanced Merkel cell carcinoma with talimogene laherparepvecNeha Singh, Erin McClure, Coley Doolittle-Amieva, et al.
Cancer Medicine|January 30, 2020
Economics of alternative dosing strategies for pembrolizumab and nivolumab at a single academic cancer centerEvan Hall, Jenny Zhang, Eun Jeong Kim, et al.
Expert Review of Anticancer Therapy|January 20, 2017
Factors influencing radiation treatment recommendations in early-stage Merkel cell carcinoma: a survey of US-based radiation oncologistsYolanda D Tseng, Smith Apisarnthanarax, Jay J Liao, et al.
The American Journal of Case Reports|May 1, 2018
Clinical Benefit from Tyrosine Kinase Inhibitors in Metastatic Merkel Cell Carcinoma: A Case Series of 5 PatientsErica S Tarabadkar, Hannah Thomas, Astrid Blom, et al.
Journal for Immunotherapy of Cancer|July 25, 2024
Merkel cell carcinoma refractory to anti-PD(L)1: utility of adding ipilimumab for salvage therapyTomoko Akaike, Austin J Jabbour, Peter H Goff, et al.
Neuro-Oncology|December 30, 2016
Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanomaMarc C Chamberlain, Christina S Baik, Vijayakrishna K Gadi, et al.
Oncoimmunology|November 11, 2017
Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinomaDirk Schadendorf, Paul Nghiem, Shailender Bhatia, et al.
Pageof 13